Cargando…
Vorinostat Corrects Cognitive and Non-Cognitive Symptoms in a Mouse Model of Fragile X Syndrome
BACKGROUND: Fragile X syndrome (FXS) is caused by mutations in the FMR1 gene. It is a form of heritable intellectual disability and autism. Despite recent advance in elucidating disease mechanisms, there is no efficacious medication. Because de novo drug development is a lengthy process, repurposing...
Autores principales: | Ding, Qi, Wu, Xueting, Li, Xuan, Wang, Hongbing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8832232/ https://www.ncbi.nlm.nih.gov/pubmed/34791268 http://dx.doi.org/10.1093/ijnp/pyab081 |
Ejemplares similares
-
Carbamazepine Restores Neuronal Signaling, Protein Synthesis, and Cognitive Function in a Mouse Model of Fragile X Syndrome
por: Ding, Qi, et al.
Publicado: (2020) -
Transcriptome signature analysis repurposes trifluoperazine for the treatment of fragile X syndrome in mouse model
por: Ding, Qi, et al.
Publicado: (2020) -
Targeted Therapy of Cognitive Deficits in Fragile X Syndrome
por: Puścian, A., et al.
Publicado: (2022) -
Reducing histone acetylation rescues cognitive deficits in a mouse model of Fragile X syndrome
por: Li, Yue, et al.
Publicado: (2018) -
Profiles of aberrant white matter microstructure in fragile X syndrome
por: Hall, Scott S., et al.
Publicado: (2016)